◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksGMED › Net Income

Globus Medical (GMED) Net Income 2009–TTM

DATA UPDATED 2026-09-19

Globus Medical annual net income for fiscal TTM was $536 million, a decrease of 0.4% from $538 million in fiscal 2025. All figures are reported results from public filings — no estimates or projections.

GMED Annual Net Income

Net Income (annual)TTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-31
Net Income$536M$538M$103M$123M$190M$149M$102M$155M$156M$107M$104M$113M$92M$69M$74M$61M$54M$49M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

GMED Quarterly Net Income

Net Income (quarterly)2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Net Income$152M$124M$141M$119M$203M$75M$27M$52M$32M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Net Income at Comparable Companies

More GMED metrics: Revenue · Gross Profit · Operating Income · EPS · EBITDA · Free Cash Flow · Shares Outstanding

All GMED financial statements → Interactive GMED charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.